Pharma Execs Continue Looking For Growth Opportunities In Spite Of Increasing Regulatory Challenges: KPMG Survey

Moderate Revenue, Sector Growth Expected; M&A Slows

Jun 22, 2012, 08:00 ET from KPMG LLP

$countyNameToPathMap.put("sp